Clickable Photoaffinity Ligands for Metabotropic Glutamate Receptor 5 Based on Select Acetylenic Negative Allosteric Modulators.
G protein-coupled receptors (GPCRs) represent the largest class of current drug targets. In particular, small-molecule allosteric modulators offer substantial potential for selectively "tuning" GPCR activity. However, there remains a critical need for experimental strategies that unambiguously determine direct allosteric ligand-GPCR interactions, to facilitate both chemical biology studies and rational structure-based drug design. We now report the development and use of first-in-class clickable allosteric photoprobes for a GPCR based on metabotropic glutamate receptor 5 (mGlu5) negative allosteric modulator (NAM) chemotypes. Select acetylenic mGlu5 NAM lead compounds were rationally modified to contain either a benzophenone or an aryl azide as a photoreactive functional group, enabling irreversible covalent attachment to mGlu5 via photoactivation. Additionally, a terminal alkyne or an aliphatic azide was incorporated as a click chemistry handle, allowing chemoselective attachment of fluorescent moieties to the irreversibly mGlu5-bound probe via tandem photoaffinity labeling-bioorthogonal conjugation. These clickable photoprobes retained submicromolar affinity for mGlu5 and negative cooperativity with glutamate, interacted with the "common allosteric-binding site," displayed slow binding kinetics, and could irreversibly label mGlu5 following UV exposure. We depleted the number of functional mGlu5 receptors using an irreversibly bound NAM to elucidate and delineate orthosteric agonist affinity and efficacy. Finally, successful conjugation of fluorescent dyes via click chemistry was demonstrated for each photoprobe. In the future, these clickable photoprobes are expected to aid our understanding of the structural basis of mGlu5 allosteric modulation. Furthermore, tandem photoaffinity labeling-bioorthogonal conjugation is expected to be a broadly applicable experimental strategy across the entire GPCR superfamily.
Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences and Department of Pharmacology, Monash University , Parkville, Victoria, Australia.
Karen J
KJ
Gregory
Division of Pharmaceutical Sciences, Mylan School of Pharmacy, Duquesne University , Pittsburgh, Pennsylvania, United States.
Ranganadh
R
Velagaleti
Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences and Department of Pharmacology, Monash University , Parkville, Victoria, Australia.
David M
DM
Thal
Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences and Department of Pharmacology, Monash University , Parkville, Victoria, Australia.
Ryan M
RM
Brady
Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences and Department of Pharmacology, Monash University , Parkville, Victoria, Australia.
Arthur
A
Christopoulos
Vanderbilt Center for Neuroscience Drug Discovery and Department of Pharmacology, Vanderbilt University Medical Center , Nashville, Tennessee, United States.
P Jeffrey
PJ
Conn
Division of Pharmaceutical Sciences, Mylan School of Pharmacy, Duquesne University , Pittsburgh, Pennsylvania, United States.
David J
DJ
Lapinsky
D000114:Acetylene / Q000378:metabolism*; D000494:Allosteric Regulation; D057930:Click Chemistry; D057809:HEK293 Cells; D006801:Humans; D008024:Ligands; D019920:Photoaffinity Labels; D011869:Radioligand Assay; D064529:Receptor, Metabotropic Glutamate 5 / Q000378:metabolism*
D008024:Ligands; D019920:Photoaffinity Labels; D064529:Receptor, Metabotropic Glutamate 5; D000114:Acetylene